Novo Nordisk partners with Anthropic to accelerate drug development
Novo Nordisk A/S and Anthropic announced on September 16, 2026 a partnership to use artificial intelligence, specifically Claude, to speed drug development. The collaboration aims to help Novo compete in the obesity treatment market.